Your browser doesn't support javascript.
loading
Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension.
Tamura, Yuichi; Kumamaru, Hiraku; Nishimura, Shiori; Nakajima, Yasuo; Matsubara, Hiromi; Taniguchi, Yu; Tsujino, Ichizo; Shigeta, Ayako; Kinugawa, Koichiro; Kimura, Kazuhiro; Tatsumi, Koichiro.
Afiliação
  • Tamura Y; Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital.
  • Kumamaru H; Japan Pulmonary Hypertension Registry (JAPHR) Network.
  • Nishimura S; Japan Pulmonary Hypertension Registry (JAPHR) Network.
  • Nakajima Y; Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo.
  • Matsubara H; Japan Pulmonary Hypertension Registry (JAPHR) Network.
  • Taniguchi Y; Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo.
  • Tsujino I; Medical Division, GSK K.K.
  • Shigeta A; Japan Pulmonary Hypertension Registry (JAPHR) Network.
  • Kinugawa K; National Hospital Organization Okayama Medical Center.
  • Kimura K; Japan Pulmonary Hypertension Registry (JAPHR) Network.
  • Tatsumi K; Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
Int Heart J ; 64(4): 684-692, 2023.
Article em En | MEDLINE | ID: mdl-37518350
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article